Back to Results

American Well Corp (AMWL)

Featured in High-Beta Stocks High-Momentum Stocks Technical Strength Leaders High-Beta Momentum

American Well Corporation is a healthcare technology company listed on the NYSE under the ticker AMWL. The company develops enterprise software and digital care tools designed to support hybrid care delivery in the United States and international markets. Its product suite includes the Amwell Platform, a cloud-based enablement platform for use across care settings, as well as Amwell Carepoint, which uses proprietary devices to turn tablets and televisions into digital access points in clinical environments. The company also provides Amwell Converge, behavioral health platforms for higher education settings, and specialty care programs covering areas such as dermatology, musculoskeletal care, second opinion, and cardiometabolic care. In addition, American Well offers professional services, implementation support, workflow design, systems integration, and patient and provider engagement services. Its customer base includes providers, payers, government entities, and higher education institutions. Founded in 2006, the company is headquartered in Boston, Massachusetts.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-AMWL
$13.86
13.8% Upside
Fair
$8.90
-26.9% Downside
Overvalued
Great
—
—
—
0.0%
August 5, 2026
-2.3x
0.9x
0.9x
210.2 M
41.512 M
1.7%
70.2%
-8.8
—
47.6%
Send a message
Valuation • Fair Value

American Well Corp (NYSE-AMWL) Fair Value by Valuation Model

Compare the primary fair value estimate for American Well Corp (NYSE-AMWL) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$13.86

Estimated upside of 13.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$14.61

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$13.10

Comparable-company valuation reference.

Analyst Price Target

$8.90

Analysts imply downside of 26.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for American Well Corp (NYSE-AMWL) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for American Well Corp (NYSE-AMWL)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

237.4 M

Current operating scale indicator.

Revenue Forecast

202.3 M

Forward revenue estimate.

EBITDA

-46.32 M

Current operating profitability reference.

EBITDA Forecast

-13.838 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review American Well Corp (NYSE-AMWL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for American Well Corp (NYSE-AMWL)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-3.47

No elevated caution signal from this screen.

Altman Z-Score

-8.8

Lower score that deserves closer risk review.

FCF / Net Income

47.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for American Well Corp (NYSE-AMWL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for American Well Corp (NYSE-AMWL)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 5, 2026

Days to Earnings

15

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for American Well Corp (NYSE-AMWL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

American Well Corp (NYSE-AMWL) Stock Forecast & Technical Outlook

Review American Well Corp (NYSE-AMWL) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for American Well Corp (NYSE-AMWL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for American Well Corp (NYSE-AMWL) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for American Well Corp (NYSE-AMWL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for American Well Corp (NYSE-AMWL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for American Well Corp (NYSE-AMWL) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for American Well Corp (NYSE-AMWL)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, American Well Corp (NYSE-AMWL) has a Hold consensus, with 1 buy, 6 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 6
Sell 0
FAQ • Fast Investor Answers

American Well Corp (NYSE-AMWL) Stock FAQ

Quick answers about American Well Corp (NYSE-AMWL) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$13.86
Estimated upside 13.8%
Valuation Rating
Undervalued
Estimated upside of 13.8%
Analyst Target
$8.90
Implied downside 26.9%
Financial Health
Great
Current financial-health read

The current fair value estimate for American Well Corp (NYSE-AMWL) is $13.86. This implies an estimated upside of 13.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 13.8% versus the current market price.

The available analyst price target for American Well Corp (NYSE-AMWL) is $8.90. The analyst target implies estimated downside of 26.9%.

The current financial health read for American Well Corp (NYSE-AMWL) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for American Well Corp (NYSE-AMWL) is August 5, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for American Well Corp (NYSE-AMWL) is -2.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for American Well Corp is 210.2 M.

The current enterprise value listed for American Well Corp is 41.512 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for American Well Corp is NYSE-AMWL, and the stock is listed on NYSE.

American Well Corp (NYSE-AMWL) is listed on NYSE.

The current debt-to-total-capital ratio listed for American Well Corp is 1.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for American Well Corp is 70.2%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks on NYSE View more

Veeva Systems Inc Class A (VEEV) Veeva Systems Inc Class A (VEEV)
Doximity Inc (DOCS) Doximity Inc (DOCS)
Teladoc Inc (TDOC) Teladoc Inc (TDOC)
Evolent Health Inc (EVH) Evolent Health Inc (EVH)
Phreesia Inc (PHR) Phreesia Inc (PHR)
Claritev Corp (CTEV) Claritev Corp (CTEV)